{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:47Z","timestamp":1787003687977,"version":"build-2736575974"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004282","name":"Evelyn Trust","doi-asserted-by":"publisher","award":["24\/08 Med-24-2313"],"award-info":[{"award-number":["24\/08 Med-24-2313"]}],"id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["2018\/R\/14"],"award-info":[{"award-number":["2018\/R\/14"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["FIMS 2018\/R\/14 and 2022\/R-Single\/011"],"award-info":[{"award-number":["FIMS 2018\/R\/14 and 2022\/R-Single\/011"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["1802-30200 and RFA-2203-39318"],"award-info":[{"award-number":["1802-30200 and RFA-2203-39318"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 1802-30200 and RFA-2203-39318"],"award-info":[{"award-number":["RG 1802-30200 and RFA-2203-39318"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Demyelinating disorders such as multiple sclerosis and leukodystrophies are on the rise, posing substantial challenges due to their progressive nature and the current limitations of therapies that effectively restore lost myelin. Over the past decade, advancements in regenerative neuroscience, including cutting-edge stem cell therapies, advanced biomaterials and groundbreaking gene-editing technologies, offer promising avenues for remyelination, immunomodulation and neural repair. Yet, to successfully transition these innovations into clinical therapies, we need robust preclinical models that accurately reflect disease pathology and predict treatment efficacy. This Review offers a thorough overview of the preclinical models utilized in regenerative neurology for demyelinating diseases, highlighting the rapid progress in biomaterial and gene-editing research, which requires meticulous testing and validation in both in vitro and in vivo environments. We begin by explaining the pathophysiology of demyelination, then provide an exhaustive discussion on various preclinical models, including toxin-induced, autoimmune, genetic, viral-induced and large animal models. This is followed by an exploration of emerging regenerative strategies, from cell-based and pharmacological approaches to bioengineered techniques, and we conclude with an analysis of current challenges, translational barriers and future directions in the field. By synthesizing insights from multiple disciplines, this Review strives to engage a diverse audience eager to connect laboratory discoveries with clinical applications in regenerative neuroscience.<\/jats:p>","DOI":"10.1038\/s41684-026-01725-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:03:04Z","timestamp":1776416584000},"page":"201-217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics"],"prefix":"10.1038","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7414-5937","authenticated-orcid":false,"given":"Melika","family":"Karbalaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9396-5607","authenticated-orcid":false,"given":"Luca","family":"Peruzzotti-Jametti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-9472","authenticated-orcid":false,"given":"Stefano","family":"Pluchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-2465","authenticated-orcid":false,"given":"Sabah","family":"Mozafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1725_CR1","doi-asserted-by":"publisher","first-page":"149844","DOI":"10.1016\/j.brainres.2025.149844","volume":"1863","author":"NS Gupta","year":"2025","unstructured":"Gupta, N. S. et al. Decoding the molecular and cellular aspects of multiple sclerosis: from diagnosis to therapeutic strategies. Brain Res. 1863, 149844 (2025).","journal-title":"Brain Res."},{"key":"1725_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-025-01432-8","volume":"25","author":"A Mukherjee","year":"2025","unstructured":"Mukherjee, A., Roy, D. & Chakravarty, A. Uncommon non-MS demyelinating disorders of the central nervous system. Curr. Neurol. Neurosci. Rep. 25, 45 (2025).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1725_CR3","doi-asserted-by":"publisher","first-page":"1207007","DOI":"10.3389\/fnmol.2023.1207007","volume":"16","author":"D Packer","year":"2023","unstructured":"Packer, D., Fresenko, E. E. & Harrington, E. P. Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration. Front. Mol. Neurosci. 16, 1207007 (2023).","journal-title":"Front. Mol. Neurosci."},{"key":"1725_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.clinthera.2014.08.006","volume":"36","author":"MD Carrithers","year":"2014","unstructured":"Carrithers, M. D. Update on disease-modifying treatments for multiple sclerosis. Clin. Ther. 36, 1938\u20131945 (2014).","journal-title":"Clin. Ther."},{"key":"1725_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/joim.13215","volume":"289","author":"F Piehl","year":"2021","unstructured":"Piehl, F. Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis. J. Intern. Med. 289, 771\u2013791 (2021).","journal-title":"J. Intern. Med."},{"key":"1725_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","volume":"19","author":"C Lubetzki","year":"2020","unstructured":"Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C. & Stankoff, B. Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol. 19, 678\u2013688 (2020).","journal-title":"Lancet Neurol."},{"key":"1725_CR7","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green, A. J. et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 390, 2481\u20132489 (2017).","journal-title":"Lancet"},{"key":"1725_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/jnr.25173","volume":"101","author":"A McCaughey-Chapman","year":"2023","unstructured":"McCaughey-Chapman, A. & Connor, B. Cell reprogramming for oligodendrocytes: a review of protocols and their applications to disease modeling and cell-based remyelination therapies. J. Neurosci. Res. 101, 1000\u20131028 (2023).","journal-title":"J. Neurosci. Res."},{"key":"1725_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.21745","volume":"66","author":"S Pluchino","year":"2009","unstructured":"Pluchino, S. et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann. Neurol. 66, 343\u2013354 (2009).","journal-title":"Ann. Neurol."},{"key":"1725_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cellimm.2015.01.002","volume":"293","author":"T Gharibi","year":"2015","unstructured":"Gharibi, T., Ahmadi, M., Seyfizadeh, N., Jadidi-Niaragh, F. & Yousefi, M. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis. Cell. Immunol. 293, 113\u2013121 (2015).","journal-title":"Cell. Immunol."},{"key":"1725_CR11","doi-asserted-by":"publisher","first-page":"eadk9918","DOI":"10.1126\/sciadv.adk9918","volume":"10","author":"A Kumar Podder","year":"2024","unstructured":"Kumar Podder, A. et al. Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system. Sci. Adv. 10, eadk9918 (2024).","journal-title":"Sci. Adv."},{"key":"1725_CR12","doi-asserted-by":"publisher","first-page":"121427","DOI":"10.1016\/j.biomaterials.2022.121427","volume":"283","author":"ED Carvalho","year":"2022","unstructured":"Carvalho, E. D. et al. A paradigm shift: bioengineering meets mechanobiology towards overcoming remyelination failure. Biomaterials 283, 121427 (2022).","journal-title":"Biomaterials"},{"key":"1725_CR13","doi-asserted-by":"publisher","unstructured":"Ojeda-Hernandez, D. D. et al. Exosomes and biomaterials: in search of a new therapeutic strategy for multiple sclerosis. Life https:\/\/doi.org\/10.3390\/life12091417 (2022).","DOI":"10.3390\/life12091417"},{"key":"1725_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00018-024-05391-0","volume":"81","author":"PT Nguyen","year":"2024","unstructured":"Nguyen, P. T. et al. Low intensity repetitive transcranial magnetic stimulation enhances remyelination by newborn and surviving oligodendrocytes in the cuprizone model of toxic demyelination. Cell. Mol. Life Sci. 81, 346 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"1725_CR15","doi-asserted-by":"publisher","first-page":"102459","DOI":"10.1016\/j.pneurobio.2023.102459","volume":"226","author":"TJ Scheinok","year":"2023","unstructured":"Scheinok, T. J., D\u2019Haeseleer, M., Nagels, G., De Bundel, D. & Van Schependom, J. Neuronal activity and NIBS in developmental myelination and remyelination\u2014current state of knowledge. Prog. Neurobiol. 226, 102459 (2023).","journal-title":"Prog. Neurobiol."},{"key":"1725_CR16","doi-asserted-by":"publisher","first-page":"748849","DOI":"10.3389\/fncel.2021.748849","volume":"15","author":"D Marangon","year":"2021","unstructured":"Marangon, D. et al. Novel in vitro experimental approaches to study myelination and remyelination in the central nervous system. Front. Cell. Neurosci. 15, 748849 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"1725_CR17","doi-asserted-by":"publisher","first-page":"1488691","DOI":"10.3389\/fncel.2024.1488691","volume":"18","author":"MBC Simoes-Abade","year":"2024","unstructured":"Simoes-Abade, M. B. C., Patterer, M., Nicaise, A. M. & Pluchino, S. Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis. Front. Cell. Neurosci. 18, 1488691 (2024).","journal-title":"Front. Cell. Neurosci."},{"key":"1725_CR18","doi-asserted-by":"publisher","unstructured":"Czpakowska, J., Kaluza, M., Szpakowski, P. & Glabinski, A. An overview of multiple sclerosis in vitro models. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25147759 (2024).","DOI":"10.3390\/ijms25147759"},{"key":"1725_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/WCO.0b013e328346c226","volume":"24","author":"AR Pachner","year":"2011","unstructured":"Pachner, A. R. Experimental models of multiple sclerosis. Curr. Opin. Neurol. 24, 291\u2013299 (2011).","journal-title":"Curr. Opin. Neurol."},{"key":"1725_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/978-1-4939-9072-6_21","volume":"1936","author":"CE McMurran","year":"2019","unstructured":"McMurran, C. E., Zhao, C. & Franklin, R. J. M. Toxin-based models to investigate demyelination and remyelination. Methods Mol. Biol. 1936, 377\u2013396 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1725_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2040-7378-1-5","volume":"1","author":"RA Linker","year":"2009","unstructured":"Linker, R. A. & Lee, D. H. Models of autoimmune demyelination in the central nervous system: on the way to translational medicine. Exp. Transl. Stroke Med. 1, 5 (2009).","journal-title":"Exp. Transl. Stroke Med."},{"key":"1725_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1469-7580.2011.01363.x","volume":"219","author":"FI Gruenenfelder","year":"2011","unstructured":"Gruenenfelder, F. I., Thomson, G., Penderis, J. & Edgar, J. M. Axon\u2013glial interaction in the CNS: what we have learned from mouse models of Pelizaeus\u2013Merzbacher disease. J. Anat. 219, 33\u201343 (2011).","journal-title":"J. Anat."},{"key":"1725_CR23","doi-asserted-by":"publisher","unstructured":"Mozafari, S. et al. Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abc6983 (2020).","DOI":"10.1126\/sciadv.abc6983"},{"key":"1725_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00705-021-04968-5","volume":"166","author":"JE Libbey","year":"2021","unstructured":"Libbey, J. E. & Fujinami, R. S. Viral mouse models used to study multiple sclerosis: past and present. Arch. Virol 166, 1015\u20131033 (2021).","journal-title":"Arch. Virol"},{"key":"1725_CR25","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1172\/JCI80437","volume":"125","author":"S Mozafari","year":"2015","unstructured":"Mozafari, S. et al. Skin-derived neural precursors competitively generate functional myelin in adult demyelinated mice. J. Clin. Invest. 125, 3642\u20133656 (2015).","journal-title":"J. Clin. Invest."},{"key":"1725_CR26","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/glia.23202","volume":"65","author":"BJ Ruther","year":"2017","unstructured":"Ruther, B. J. et al. Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression. Glia 65, 1900\u20131913 (2017).","journal-title":"Glia"},{"key":"1725_CR27","doi-asserted-by":"publisher","first-page":"1006106","DOI":"10.37349\/en.2025.1006106","volume":"4","author":"DM Hermann","year":"2025","unstructured":"Hermann, D. M. et al. Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation. Explor. Neurosci. 4, 1006106 (2025).","journal-title":"Explor. Neurosci."},{"key":"1725_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","volume":"25","author":"MS Woo","year":"2024","unstructured":"Woo, M. S., Engler, J. B. & Friese, M. A. The neuropathobiology of multiple sclerosis. Nat. Rev. Neurosci. 25, 493\u2013513 (2024).","journal-title":"Nat. Rev. Neurosci."},{"key":"1725_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1515\/revneuro-2023-0091","volume":"35","author":"A Sanabria-Castro","year":"2024","unstructured":"Sanabria-Castro, A., Alape-Giron, A., Flores-Diaz, M., Echeverri-McCandless, A. & Parajeles-Vindas, A. Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review. Rev. Neurosci. 35, 355\u2013371 (2024).","journal-title":"Rev. Neurosci."},{"key":"1725_CR30","doi-asserted-by":"publisher","first-page":"e200340","DOI":"10.1212\/NXI.0000000000200340","volume":"12","author":"J Villacieros-Alvarez","year":"2025","unstructured":"Villacieros-Alvarez, J. et al. Complement activation profiles predict clinical outcomes in myelin oligodendrocyte glycoprotein antibody-associated disease. Neurol. Neuroimmunol. Neuroinflamm. 12, e200340 (2025).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1725_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41582-025-01081-y","volume":"21","author":"MS van der Knaap","year":"2025","unstructured":"van der Knaap, M. S. & Min, R. Multiple sclerosis: an immune attack on astrocyte-mediated ion and water homeostasis. Nat. Rev. Neurol. 21, 283\u2013289 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"1725_CR32","doi-asserted-by":"publisher","unstructured":"International Multiple Sclerosis Genetics, C. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science https:\/\/doi.org\/10.1126\/science.aav7188 (2019).","DOI":"10.1126\/science.aav7188"},{"key":"1725_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s42003-023-04713-5","volume":"6","author":"Q Ma","year":"2023","unstructured":"Ma, Q. et al. Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes. Commun. Biol. 6, 342 (2023).","journal-title":"Commun. Biol."},{"key":"1725_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00401-024-02733-x","volume":"147","author":"F Windener","year":"2024","unstructured":"Windener, F. et al. Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS. Acta Neuropathol. 147, 82 (2024).","journal-title":"Acta Neuropathol."},{"key":"1725_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s43587-025-00840-2","volume":"5","author":"D Heo","year":"2025","unstructured":"Heo, D. et al. Transcriptional profiles of mouse oligodendrocyte precursor cells across the lifespan. Nat. Aging 5, 675\u2013690 (2025).","journal-title":"Nat. Aging"},{"key":"1725_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10522-025-10213-2","volume":"26","author":"R Jana","year":"2025","unstructured":"Jana, R. & Das Sarma, J. The crosstalk between CNS resident glial cells and peripheral immune cells is critical for age-dependent demyelination and subsequent remyelination. Biogerontology 26, 74 (2025).","journal-title":"Biogerontology"},{"key":"1725_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12017-017-8442-1","volume":"19","author":"I Osorio-Querejeta","year":"2017","unstructured":"Osorio-Querejeta, I., Saenz-Cuesta, M., Munoz-Culla, M. & Otaegui, D. Models for studying myelination, demyelination and remyelination. Neuromolecular Med. 19, 181\u2013192 (2017).","journal-title":"Neuromolecular Med."},{"key":"1725_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nrl.2017.07.002","volume":"35","author":"L Torre-Fuentes","year":"2020","unstructured":"Torre-Fuentes, L. et al. Experimental models of demyelination and remyelination. Neurologia 35, 32\u201339 (2020).","journal-title":"Neurologia"},{"key":"1725_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1678-1","volume":"16","author":"P Pound","year":"2018","unstructured":"Pound, P. & Ritskes-Hoitinga, M. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. J. Transl. Med. 16, 304 (2018).","journal-title":"J. Transl. Med."},{"key":"1725_CR40","doi-asserted-by":"publisher","first-page":"103327","DOI":"10.1016\/j.xpro.2024.103327","volume":"5","author":"H Kim","year":"2024","unstructured":"Kim, H. et al. Protocol for the acquisition and maturation of oligodendrocytes from neonatal rodent brains. STAR Protoc. 5, 103327 (2024).","journal-title":"STAR Protoc."},{"key":"1725_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/glia.23733","volume":"68","author":"K Chanoumidou","year":"2020","unstructured":"Chanoumidou, K., Mozafari, S., Baron-Van Evercooren, A. & Kuhlmann, T. Stem cell derived oligodendrocytes to study myelin diseases. Glia 68, 705\u2013720 (2020).","journal-title":"Glia"},{"key":"1725_CR42","doi-asserted-by":"publisher","first-page":"eabk1131","DOI":"10.1126\/sciadv.abk1131","volume":"7","author":"EN Santos","year":"2021","unstructured":"Santos, E. N. & Fields, R. D. Regulation of myelination by microglia. Sci. Adv. 7, eabk1131 (2021).","journal-title":"Sci. Adv."},{"key":"1725_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/glia.440110405","volume":"11","author":"SP Hamilton","year":"1994","unstructured":"Hamilton, S. P. & Rome, L. H. Stimulation of in vitro myelin synthesis by microglia. Glia 11, 326\u2013335 (1994).","journal-title":"Glia"},{"key":"1725_CR44","doi-asserted-by":"publisher","first-page":"113574","DOI":"10.1016\/j.celrep.2023.113574","volume":"42","author":"CS Baaklini","year":"2023","unstructured":"Baaklini, C. S. et al. Microglia promote remyelination independent of their role in clearing myelin debris. Cell Rep. 42, 113574 (2023).","journal-title":"Cell Rep."},{"key":"1725_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcdb.2020.09.011","volume":"116","author":"S Mozafari","year":"2021","unstructured":"Mozafari, S. & Baron-Van Evercooren, A. Human stem cell-derived oligodendrocytes: from humanized animal models to cell therapy in myelin diseases. Semin. Cell Dev. Biol. 116, 53\u201361 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1725_CR46","doi-asserted-by":"publisher","unstructured":"Baldassarro, V. A. High-content screening differentiation and maturation analysis of fetal and adult neural stem cell-derived oligodendrocyte precursor cell cultures. J. Vis. Exp. https:\/\/doi.org\/10.3791\/61988 (2021).","DOI":"10.3791\/61988"},{"key":"1725_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00441-017-2713-x","volume":"371","author":"L Li","year":"2018","unstructured":"Li, L., Chao, J. & Shi, Y. Modeling neurological diseases using iPSC-derived neural cells: iPSC modeling of neurological diseases. Cell Tissue Res. 371, 143\u2013151 (2018).","journal-title":"Cell Tissue Res."},{"key":"1725_CR48","doi-asserted-by":"publisher","unstructured":"Peruzzotti-Jametti, L. et al. Remyelination of chronic demyelinated lesions with directly induced neural stem cells. Brain https:\/\/doi.org\/10.1093\/brain\/awaf208 (2025).","DOI":"10.1093\/brain\/awaf208"},{"key":"1725_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stemcr.2021.03.001","volume":"16","author":"K Chanoumidou","year":"2021","unstructured":"Chanoumidou, K. et al. One-step reprogramming of human fibroblasts into oligodendrocyte-like cells by SOX10, OLIG2, and NKX6.2. Stem Cell Rep. 16, 771\u2013783 (2021).","journal-title":"Stem Cell Rep."},{"key":"1725_CR50","doi-asserted-by":"publisher","first-page":"E2243","DOI":"10.1073\/pnas.1614412114","volume":"114","author":"M Ehrlich","year":"2017","unstructured":"Ehrlich, M. et al. Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors. Proc. Natl Acad. Sci. USA 114, E2243\u2013E2252 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1725_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00401-020-02217-8","volume":"140","author":"L Starost","year":"2020","unstructured":"Starost, L. et al. Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis. Acta Neuropathol. 140, 715\u2013736 (2020).","journal-title":"Acta Neuropathol."},{"key":"1725_CR52","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/stem.2263","volume":"34","author":"A Marteyn","year":"2016","unstructured":"Marteyn, A. et al. Modulation of the innate immune response by human neural precursors prevails over oligodendrocyte progenitor remyelination to rescue a severe model of Pelizaeus\u2013Merzbacher disease. Stem Cells 34, 984\u2013996 (2016).","journal-title":"Stem Cells"},{"key":"1725_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","volume":"12","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12, 252\u2013264 (2013).","journal-title":"Cell Stem Cell"},{"key":"1725_CR54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.stemcr.2014.06.012","volume":"3","author":"P Douvaras","year":"2014","unstructured":"Douvaras, P. et al. Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Rep. 3, 250\u2013259 (2014).","journal-title":"Stem Cell Rep."},{"key":"1725_CR55","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.stem.2024.09.014","volume":"31","author":"RB Ionescu","year":"2024","unstructured":"Ionescu, R. B. et al. Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis. Cell Stem Cell 31, 1574\u20131590 (2024).","journal-title":"Cell Stem Cell"},{"key":"1725_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.it.2024.08.004","volume":"45","author":"RA Summers","year":"2024","unstructured":"Summers, R. A., Fagiani, F., Rowitch, D. H., Absinta, M. & Reich, D. S. Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. Trends Immunol. 45, 799\u2013813 (2024).","journal-title":"Trends Immunol."},{"key":"1725_CR57","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.stem.2024.08.002","volume":"31","author":"BLL Clayton","year":"2024","unstructured":"Clayton, B. L. L. et al. Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis. Cell Stem Cell 31, 1701\u20131713 (2024).","journal-title":"Cell Stem Cell"},{"key":"1725_CR58","doi-asserted-by":"publisher","first-page":"1322813","DOI":"10.3389\/fncel.2023.1322813","volume":"17","author":"G Shim","year":"2023","unstructured":"Shim, G., Romero-Morales, A. I., Sripathy, S. R. & Maher, B. J. Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders. Front. Cell. Neurosci. 17, 1322813 (2023).","journal-title":"Front. Cell. Neurosci."},{"key":"1725_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/glia.23781","volume":"68","author":"J Hasselmann","year":"2020","unstructured":"Hasselmann, J. & Blurton-Jones, M. Human iPSC-derived microglia: a growing toolset to study the brain\u2019s innate immune cells. Glia 68, 721\u2013739 (2020).","journal-title":"Glia"},{"key":"1725_CR60","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/glia.24343","volume":"71","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Interactions of glial cells with neuronal synapses, from astrocytes to microglia and oligodendrocyte lineage cells. Glia 71, 1383\u20131401 (2023).","journal-title":"Glia"},{"key":"1725_CR61","doi-asserted-by":"publisher","unstructured":"Assetta, B. et al. Generation of human neurons and oligodendrocytes from pluripotent stem cells for modeling neuron\u2013oligodendrocyte interactions. J. Vis. Exp. https:\/\/doi.org\/10.3791\/61778 (2020).","DOI":"10.3791\/61778"},{"key":"1725_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56484-8","volume":"16","author":"LP Fang","year":"2025","unstructured":"Fang, L. P. et al. Oligodendrocyte precursor cells facilitate neuronal lysosome release. Nat. Commun. 16, 1175 (2025).","journal-title":"Nat. Commun."},{"key":"1725_CR63","doi-asserted-by":"publisher","first-page":"102164","DOI":"10.1016\/j.xpro.2023.102164","volume":"4","author":"M von der Bey","year":"2023","unstructured":"von der Bey, M., De Cicco, S., Zach, S., Hengerer, B. & Ercan-Herbst, E. Three-dimensional co-culture platform of human induced pluripotent stem cell-derived oligodendrocyte lineage cells and neurons for studying myelination. STAR Protoc. 4, 102164 (2023).","journal-title":"STAR Protoc."},{"key":"1725_CR64","doi-asserted-by":"publisher","first-page":"e5227","DOI":"10.21769\/BioProtoc.5227","volume":"15","author":"SE Chie","year":"2025","unstructured":"Chie, S. E. et al. Human iPSC-derived neuron and oligodendrocyte co-culture as a small-molecule screening assay for myelination. Bio. Protoc. 15, e5227 (2025).","journal-title":"Bio. Protoc."},{"key":"1725_CR65","doi-asserted-by":"publisher","unstructured":"Sabet, M. F. et al. Myelinating co-culture as a model to study anti-NMDAR neurotoxicity. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24010248 (2022).","DOI":"10.3390\/ijms24010248"},{"key":"1725_CR66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/mmr.2017.6673","volume":"16","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60. Mol. Med. Rep. 16, 603\u2013608 (2017).","journal-title":"Mol. Med. Rep."},{"key":"1725_CR67","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1189\/jlb.3RI1116-494R","volume":"101","author":"VE Miron","year":"2017","unstructured":"Miron, V. E. Microglia-driven regulation of oligodendrocyte lineage cells, myelination, and remyelination. J. Leukoc. Biol. 101, 1103\u20131108 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"1725_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39046-8","volume":"14","author":"I Molina-Gonzalez","year":"2023","unstructured":"Molina-Gonzalez, I. et al. Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration. Nat. Commun. 14, 3372 (2023).","journal-title":"Nat. Commun."},{"key":"1725_CR69","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00401-019-02049-1","volume":"138","author":"M Lombardi","year":"2019","unstructured":"Lombardi, M. et al. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure. Acta Neuropathol. 138, 987\u20131012 (2019).","journal-title":"Acta Neuropathol."},{"key":"1725_CR70","doi-asserted-by":"publisher","first-page":"112841","DOI":"10.1016\/j.celrep.2023.112841","volume":"42","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model. Cell Rep. 42, 112841 (2023).","journal-title":"Cell Rep."},{"key":"1725_CR71","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.stem.2018.07.009","volume":"23","author":"L Li","year":"2018","unstructured":"Li, L. et al. GFAP Mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in an hiPSC model of Alexander disease. Cell Stem Cell 23, 239\u2013251 (2018).","journal-title":"Cell Stem Cell"},{"key":"1725_CR72","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1016\/j.neuron.2022.10.004","volume":"110","author":"B Cakir","year":"2022","unstructured":"Cakir, B., Kiral, F. R. & Park, I. H. Advanced in vitro models: microglia in action. Neuron 110, 3444\u20133457 (2022).","journal-title":"Neuron"},{"key":"1725_CR73","doi-asserted-by":"publisher","first-page":"109454","DOI":"10.1016\/j.isci.2024.109454","volume":"27","author":"TJY Birkle","year":"2024","unstructured":"Birkle, T. J. Y., Willems, H. M. G., Skidmore, J. & Brown, G. C. Disease phenotypic screening in neuron\u2013glia cocultures identifies blockers of inflammatory neurodegeneration. iScience 27, 109454 (2024).","journal-title":"iScience"},{"key":"1725_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02304-x","volume":"23","author":"I Tujula","year":"2025","unstructured":"Tujula, I. et al. Modeling neuroinflammatory interactions between microglia and astrocytes in a human iPSC-based coculture platform. Cell Commun. Signal. 23, 298 (2025).","journal-title":"Cell Commun. Signal."},{"key":"1725_CR75","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.stem.2018.01.020","volume":"22","author":"L Peruzzotti-Jametti","year":"2018","unstructured":"Peruzzotti-Jametti, L. et al. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation. Cell Stem Cell 22, 355\u2013368 (2018).","journal-title":"Cell Stem Cell"},{"key":"1725_CR76","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s13287-025-04489-x","volume":"16","author":"W Wang","year":"2025","unstructured":"Wang, W. et al. AKT signaling upregulates BDNF expression in induced neural stem cells that interact with microglia. Stem Cell Res. Ther. 16, 392 (2025).","journal-title":"Stem Cell Res. Ther."},{"key":"1725_CR77","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00441-021-03554-0","volume":"387","author":"AM Nicaise","year":"2022","unstructured":"Nicaise, A. M. et al. The role of neural stem cells in regulating glial scar formation and repair. Cell Tissue Res. 387, 399\u2013414 (2022).","journal-title":"Cell Tissue Res."},{"key":"1725_CR78","doi-asserted-by":"publisher","unstructured":"Monteiro, A. R., Barbosa, D. J., Remiao, F. & Silva, R. Co-culture models: key players in in vitro neurotoxicity, neurodegeneration and BBB modeling studies. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines12030626 (2024).","DOI":"10.3390\/biomedicines12030626"},{"key":"1725_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44675-6","volume":"13","author":"A Jagielska","year":"2023","unstructured":"Jagielska, A. et al. Artificial axons as a biomimetic 3D myelination platform for the discovery and validation of promyelinating compounds. Sci. Rep. 13, 19529 (2023).","journal-title":"Sci. Rep."},{"key":"1725_CR80","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.actbio.2025.05.027","volume":"200","author":"A Minopoli","year":"2025","unstructured":"Minopoli, A. et al. Biomaterial-driven 3D scaffolds for immune cell expansion toward personalized immunotherapy. Acta Biomater. 200, 132\u2013157 (2025).","journal-title":"Acta Biomater."},{"key":"1725_CR81","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-024-01852-x","volume":"9","author":"P Lu","year":"2024","unstructured":"Lu, P. et al. Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. Signal Transduct. Target. Ther. 9, 166 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1725_CR82","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1021\/acsbiomaterials.4c01455","volume":"11","author":"RA Mazur","year":"2025","unstructured":"Mazur, R. A. & Lampe, K. J. Guiding oligodendrocyte progenitor cell maturation using electrospun fiber cues in a 3d hyaluronic acid hydrogel culture system. ACS Biomater. Sci. Eng. 11, 1025\u20131037 (2025).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"1725_CR83","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1021\/acsptsci.2c00232","volume":"6","author":"JC Terek","year":"2023","unstructured":"Terek, J. C., Hebb, M. O. & Flynn, L. E. Development of brain-derived bioscaffolds for neural progenitor cell culture. ACS Pharmacol. Transl. Sci. 6, 320\u2013333 (2023).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"1725_CR84","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41593-018-0316-9","volume":"22","author":"RM Marton","year":"2019","unstructured":"Marton, R. M. et al. Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures. Nat. Neurosci. 22, 484\u2013491 (2019).","journal-title":"Nat. Neurosci."},{"key":"1725_CR85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s42003-024-07401-0","volume":"8","author":"X Chen","year":"2025","unstructured":"Chen, X., Sun, G., Feng, L., Tian, E. & Shi, Y. Human iPSC-derived microglial cells protect neurons from neurodegeneration in long-term cultured adhesion brain organoids. Commun. Biol. 8, 30 (2025).","journal-title":"Commun. Biol."},{"key":"1725_CR86","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.devcel.2021.04.006","volume":"56","author":"OG James","year":"2021","unstructured":"James, O. G. et al. iPSC-derived myelinoids to study myelin biology of humans. Dev. Cell 56, 1346\u20131358 (2021).","journal-title":"Dev. Cell"},{"key":"1725_CR87","doi-asserted-by":"publisher","first-page":"108037","DOI":"10.1016\/j.isci.2023.108037","volume":"26","author":"L Feng","year":"2023","unstructured":"Feng, L. et al. Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases. iScience 26, 108037 (2023).","journal-title":"iScience"},{"key":"1725_CR88","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","volume":"15","author":"M Madhavan","year":"2018","unstructured":"Madhavan, M. et al. Induction of myelinating oligodendrocytes in human cortical spheroids. Nat. Methods 15, 700\u2013706 (2018).","journal-title":"Nat. Methods"},{"key":"1725_CR89","doi-asserted-by":"publisher","first-page":"1419526","DOI":"10.3389\/fncel.2024.1419526","volume":"18","author":"N Urrestizala-Arenaza","year":"2024","unstructured":"Urrestizala-Arenaza, N., Cerchio, S., Cavaliere, F. & Magliaro, C. Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive. Front. Cell. Neurosci. 18, 1419526 (2024).","journal-title":"Front. Cell. Neurosci."},{"key":"1725_CR90","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.stem.2024.09.017","volume":"31","author":"MM Onesto","year":"2024","unstructured":"Onesto, M. M., Kim, J. I. & Pasca, S. P. Assembloid models of cell\u2013cell interaction to study tissue and disease biology. Cell Stem Cell 31, 1563\u20131573 (2024).","journal-title":"Cell Stem Cell"},{"key":"1725_CR91","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.tibtech.2025.02.009","volume":"43","author":"G Maisumu","year":"2025","unstructured":"Maisumu, G. et al. Brain organoids: building higher-order complexity and neural circuitry models. Trends Biotechnol. 43, 1583\u20131598 (2025).","journal-title":"Trends Biotechnol."},{"key":"1725_CR92","doi-asserted-by":"publisher","unstructured":"Babaliari, E., Ranella, A. & Stratakis, E. Microfluidic systems for neural cell studies. Bioengineering https:\/\/doi.org\/10.3390\/bioengineering10080902 (2023).","DOI":"10.3390\/bioengineering10080902"},{"key":"1725_CR93","doi-asserted-by":"publisher","first-page":"119980","DOI":"10.1016\/j.biomaterials.2020.119980","volume":"245","author":"H Yue","year":"2020","unstructured":"Yue, H. et al. Vascularized neural constructs for ex-vivo reconstitution of blood\u2013brain barrier function. Biomaterials 245, 119980 (2020).","journal-title":"Biomaterials"},{"key":"1725_CR94","doi-asserted-by":"publisher","unstructured":"McCloskey, M. C. et al. Use of the MicroSiM (microSiM) barrier tissue platform for modeling the blood\u2013brain barrier. J. Vis. Exp. https:\/\/doi.org\/10.3791\/65258 (2024).","DOI":"10.3791\/65258"},{"key":"1725_CR95","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0081","volume":"28","author":"MC McCloskey","year":"2024","unstructured":"McCloskey, M. C. et al. Pericytes enrich the basement membrane and reduce neutrophil transmigration in an in vitro model of peripheral inflammation at the blood\u2013brain barrier. Biomater. Res. 28, 0081 (2024).","journal-title":"Biomater. Res."},{"key":"1725_CR96","doi-asserted-by":"publisher","first-page":"e08271","DOI":"10.1002\/advs.202508271","volume":"12","author":"K Chen","year":"2025","unstructured":"Chen, K. et al. Shear conditioning promotes microvascular endothelial barrier resilience in a human BBB-on-a-chip model of systemic inflammation leading to astrogliosis. Adv. Sci. 12, e08271 (2025).","journal-title":"Adv. Sci."},{"key":"1725_CR97","doi-asserted-by":"publisher","unstructured":"Li, Z., Jiang, Z., Lu, L. & Liu, Y. Microfluidic manipulation for biomedical applications in the central and peripheral nervous systems. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics15010210 (2023).","DOI":"10.3390\/pharmaceutics15010210"},{"key":"1725_CR98","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.reth.2025.02.014","volume":"29","author":"T Hiraiwa","year":"2025","unstructured":"Hiraiwa, T. et al. A human iPSC-derived myelination model for investigating fetal brain injuries. Regen. Ther. 29, 100\u2013107 (2025).","journal-title":"Regen. Ther."},{"key":"1725_CR99","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbrc.2016.11.062","volume":"482","author":"BJ van Meer","year":"2017","unstructured":"van Meer, B. J. et al. Small molecule absorption by PDMS in the context of drug response bioassays. Biochem. Biophys. Res. Commun. 482, 323\u2013328 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1725_CR100","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/glia.24570","volume":"72","author":"L Baudouin","year":"2024","unstructured":"Baudouin, L. et al. Antagonistic actions of PAK1 and NF2\/Merlin drive myelin membrane expansion in oligodendrocytes. Glia 72, 1518\u20131540 (2024).","journal-title":"Glia"},{"key":"1725_CR101","doi-asserted-by":"publisher","unstructured":"Kennedy, L., Morland, C., Narum, M., Bergersen, L. H. & Rinholm, J. E. Lactate receptor HCAR1 affects axonal development and contributes to lactate\u2019s protection of axons and myelin in experimental neonatal hypoglycemia. eNeuro https:\/\/doi.org\/10.1523\/ENEURO.0563-24.2025 (2025).","DOI":"10.1523\/ENEURO.0563-24.2025"},{"key":"1725_CR102","doi-asserted-by":"publisher","unstructured":"Yilmaz, S. N. et al. From organotypic mouse brain slices to human Alzheimer\u2019s plasma biomarkers: a focus on nerve fiber outgrowth. Biomolecules https:\/\/doi.org\/10.3390\/biom14101326 (2024).","DOI":"10.3390\/biom14101326"},{"key":"1725_CR103","doi-asserted-by":"publisher","first-page":"1345042","DOI":"10.3389\/fncel.2024.1345042","volume":"18","author":"B Hawker","year":"2024","unstructured":"Hawker, B., Dhakal, M., Connor, B. & McCaughey-Chapman, A. Modeling demyelination and endogenous remyelination in spinal cord ex vivo rat organotypic slice cultures. Front. Cell. Neurosci. 18, 1345042 (2024).","journal-title":"Front. Cell. Neurosci."},{"key":"1725_CR104","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s13311-023-01409-w","volume":"20","author":"M Mekhaeil","year":"2023","unstructured":"Mekhaeil, M., Conroy, M. J. & Dev, K. K. Olaparib attenuates demyelination and neuroinflammation in an organotypic slice culture model of metachromatic leukodystrophy. Neurotherapeutics 20, 1347\u20131368 (2023).","journal-title":"Neurotherapeutics"},{"key":"1725_CR105","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/glia.24347","volume":"71","author":"V Giacco","year":"2023","unstructured":"Giacco, V. et al. Transient receptor potential Ankyrin-1 (TRPA1) agonists suppress myelination and induce demyelination in organotypic cortical slices. Glia 71, 1402\u20131413 (2023).","journal-title":"Glia"},{"key":"1725_CR106","doi-asserted-by":"publisher","first-page":"1207540","DOI":"10.3389\/fncel.2023.1207540","volume":"17","author":"LJ Schroder","year":"2023","unstructured":"Schroder, L. J. et al. Polysialic acid promotes remyelination in cerebellar slice cultures by Siglec-E-dependent modulation of microglia polarization. Front. Cell. Neurosci. 17, 1207540 (2023).","journal-title":"Front. Cell. Neurosci."},{"key":"1725_CR107","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/bs.mcb.2021.12.011","volume":"168","author":"RP Gorter","year":"2022","unstructured":"Gorter, R. P., Dijksman, N. S., Baron, W. & Colognato, H. Investigating demyelination, efficient remyelination and remyelination failure in organotypic cerebellar slice cultures: workflow and practical tips. Methods Cell. Biol. 168, 103\u2013123 (2022).","journal-title":"Methods Cell. Biol."},{"key":"1725_CR108","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00018-023-05065-3","volume":"81","author":"DA Maas","year":"2024","unstructured":"Maas, D. A. et al. Versatile and automated workflow for the analysis of oligodendroglial calcium signals. Cell. Mol. Life Sci. 81, 15 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"1725_CR109","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/s41593-024-01749-6","volume":"27","author":"E Asadollahi","year":"2024","unstructured":"Asadollahi, E. et al. Oligodendroglial fatty acid metabolism as a central nervous system energy reserve. Nat. Neurosci. 27, 1934\u20131944 (2024).","journal-title":"Nat. Neurosci."},{"key":"1725_CR110","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1523\/JNEUROSCI.0273-07.2007","volume":"27","author":"E Eftekharpour","year":"2007","unstructured":"Eftekharpour, E. et al. Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J. Neurosci. 27, 3416\u20133428 (2007).","journal-title":"J. Neurosci."},{"key":"1725_CR111","doi-asserted-by":"publisher","first-page":"e0310663","DOI":"10.1371\/journal.pone.0310663","volume":"20","author":"NRC Meijns","year":"2025","unstructured":"Meijns, N. R. C. et al. Dynamic imaging of myelin pathology in physiologically preserved human brain tissue using third harmonic generation microscopy. PLoS ONE 20, e0310663 (2025).","journal-title":"PLoS ONE"},{"key":"1725_CR112","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-024-01784-1","volume":"12","author":"BC Plug","year":"2024","unstructured":"Plug, B. C. et al. Human post-mortem organotypic brain slice cultures: a tool to study pathomechanisms and test therapies. Acta Neuropathol. Commun. 12, 83 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"1725_CR113","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.it.2005.08.014","volume":"26","author":"L Steinman","year":"2005","unstructured":"Steinman, L. & Zamvil, S. S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26, 565\u2013571 (2005).","journal-title":"Trends Immunol."},{"key":"1725_CR114","doi-asserted-by":"publisher","first-page":"1403974","DOI":"10.3389\/fncel.2024.1403974","volume":"18","author":"EA Ucar","year":"2024","unstructured":"Ucar, E. A. et al. Carbenoxolone mitigates extensive fibrosis formation in PLP-induced EAE model and multiple sclerosis serum-exposed pericyte culture. Front. Cell. Neurosci. 18, 1403974 (2024).","journal-title":"Front. Cell. Neurosci."},{"key":"1725_CR115","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann, H. & Bradl, M. Multiple sclerosis: experimental models and reality. Acta Neuropathol. 133, 223\u2013244 (2017).","journal-title":"Acta Neuropathol."},{"key":"1725_CR116","doi-asserted-by":"publisher","first-page":"106644","DOI":"10.1016\/j.msard.2025.106644","volume":"103","author":"F Von Raison","year":"2025","unstructured":"Von Raison, F. et al. Lost in translation: rethinking animal models of progressive MS (an industry perspective). Mult. Scler. Relat. Disord. 103, 106644 (2025).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1725_CR117","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/jnr.24224","volume":"96","author":"I Bjelobaba","year":"2018","unstructured":"Bjelobaba, I., Begovic-Kupresanin, V., Pekovic, S. & Lavrnja, I. Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis. J. Neurosci. Res. 96, 1021\u20131042 (2018).","journal-title":"J. Neurosci. Res."},{"key":"1725_CR118","doi-asserted-by":"publisher","first-page":"106230","DOI":"10.1016\/j.nbd.2023.106230","volume":"184","author":"S Dedoni","year":"2023","unstructured":"Dedoni, S. et al. An overall view of the most common experimental models for multiple sclerosis. Neurobiol. Dis. 184, 106230 (2023).","journal-title":"Neurobiol. Dis."},{"key":"1725_CR119","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas, J. & Hughes, C. C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731\u20132738 (2004).","journal-title":"J. Immunol."},{"key":"1725_CR120","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI200317477","volume":"111","author":"AB Adams","year":"2003","unstructured":"Adams, A. B. et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111, 1887\u20131895 (2003).","journal-title":"J. Clin. Invest."},{"key":"1725_CR121","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/glia.23124","volume":"65","author":"F Pourabdolhossein","year":"2017","unstructured":"Pourabdolhossein, F. et al. Inflammatory demyelination induces ependymal modifications concomitant to activation of adult (SVZ) stem cell proliferation. Glia 65, 756\u2013772 (2017).","journal-title":"Glia"},{"key":"1725_CR122","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0002-9440(10)63232-4","volume":"164","author":"M Kerschensteiner","year":"2004","unstructured":"Kerschensteiner, M. et al. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am. J. Pathol. 164, 1455\u20131469 (2004).","journal-title":"Am. J. Pathol."},{"key":"1725_CR123","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/brain\/awl135","volume":"129","author":"D Merkler","year":"2006","unstructured":"Merkler, D., Ernsting, T., Kerschensteiner, M., Bruck, W. & Stadelmann, C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 129, 1972\u20131983 (2006).","journal-title":"Brain"},{"key":"1725_CR124","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2010.11.006","volume":"17","author":"BA t Hart","year":"2011","unstructured":"t Hart, B. A., Gran, B. & Weissert, R. EAE: imperfect but useful models of multiple sclerosis. Trends Mol. Med. 17, 119\u2013125 (2011).","journal-title":"Trends Mol. Med."},{"key":"1725_CR125","doi-asserted-by":"publisher","unstructured":"Zerimech, S., Nguyen, H., Vandenbark, A. A., Offner, H. & Baltan, S. Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model. Front. Mol. Med. https:\/\/doi.org\/10.3389\/fmmed.2023.1237078 (2023).","DOI":"10.3389\/fmmed.2023.1237078"},{"key":"1725_CR126","doi-asserted-by":"publisher","unstructured":"Tong, L. et al. AAV1.NT3 gene therapy mitigates the severity of autoimmune encephalomyelitis in the mouse model for multiple sclerosis. Gene Ther. https:\/\/doi.org\/10.1038\/s41434-025-00518-9 (2025).","DOI":"10.1038\/s41434-025-00518-9"},{"key":"1725_CR127","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2217\/imt-2021-0045","volume":"14","author":"MM Ghorbani","year":"2022","unstructured":"Ghorbani, M. M. et al. Treatment of EAE mice with Treg, G-MDSC and IL-2: a new insight into cell therapy for multiple sclerosis. Immunotherapy 14, 789\u2013798 (2022).","journal-title":"Immunotherapy"},{"key":"1725_CR128","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/acn3.84","volume":"1","author":"LH Kasper","year":"2014","unstructured":"Kasper, L. H. & Reder, A. T. Immunomodulatory activity of interferon-beta. Ann. Clin. Transl. Neurol. 1, 622\u2013631 (2014).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1725_CR129","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.autrev.2007.02.003","volume":"6","author":"W Schrempf","year":"2007","unstructured":"Schrempf, W. & Ziemssen, T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun. Rev. 6, 469\u2013475 (2007).","journal-title":"Autoimmun. Rev."},{"key":"1725_CR130","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun, J. & Hartung, H. P. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin. Neuropharmacol. 33, 91\u2013101 (2010).","journal-title":"Clin. Neuropharmacol."},{"key":"1725_CR131","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1527-3458.2007.00003.x","volume":"13","author":"O Stuve","year":"2007","unstructured":"Stuve, O. & Bennett, J. L. Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases. CNS Drug Rev. 13, 79\u201395 (2007).","journal-title":"CNS Drug Rev."},{"key":"1725_CR132","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/15376516.2016.1172284","volume":"26","author":"M Faizi","year":"2016","unstructured":"Faizi, M. et al. Toxicity of cuprizone a Cu2+ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction. Toxicol. Mech. Methods 26, 276\u2013283 (2016).","journal-title":"Toxicol. Mech. Methods"},{"key":"1725_CR133","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-60761-720-4_20","volume":"900","author":"P Acs","year":"2012","unstructured":"Acs, P. & Kalman, B. Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model. Methods Mol. Biol. 900, 403\u2013431 (2012).","journal-title":"Methods Mol. Biol."},{"key":"1725_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56092-6","volume":"16","author":"G Della-Flora Nunes","year":"2025","unstructured":"Della-Flora Nunes, G. et al. Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function. Nat. Commun. 16, 732 (2025).","journal-title":"Nat. Commun."},{"key":"1725_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64501-x","volume":"14","author":"F Velez-Uriza","year":"2024","unstructured":"Velez-Uriza, F., Ordaz, R. P., Garay, E., Cisneros-Mejorado, A. J. & Arellano, R. O. N-butyl-beta-carboline-3-carboxylate (beta-CCB) systemic administration promotes remyelination in the cuprizone demyelinating model in mice. Sci. Rep. 14, 13988 (2024).","journal-title":"Sci. Rep."},{"key":"1725_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118027","volume":"186","author":"G Noorzehi","year":"2025","unstructured":"Noorzehi, G. et al. Valproic acid preconditioning of bone marrow mesenchymal stem cells promotes remyelination of the corpus callosum in a cuprizone-induced demyelination model. Biomed. Pharmacother. 186, 118027 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"1725_CR137","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13578-017-0181-3","volume":"7","author":"Q Yu","year":"2017","unstructured":"Yu, Q. et al. Strain differences in cuprizone induced demyelination. Cell Biosci. 7, 59 (2017).","journal-title":"Cell Biosci."},{"key":"1725_CR138","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12017-011-8143-0","volume":"13","author":"S Mozafari","year":"2011","unstructured":"Mozafari, S. et al. Analysis of structural and molecular events associated with adult rat optic chiasm and nerves demyelination and remyelination: possible role for 3rd ventricle proliferating cells. Neuromol. Med. 13, 138\u2013150 (2011).","journal-title":"Neuromol. Med."},{"key":"1725_CR139","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L","volume":"25","author":"RH Woodruff","year":"1999","unstructured":"Woodruff, R. H. & Franklin, R. J. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement\/anti-galactocerebroside: a comparative study. Glia 25, 216\u2013228 (1999).","journal-title":"Glia"},{"key":"1725_CR140","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0022-2836(65)80096-1","volume":"13","author":"MJ Waring","year":"1965","unstructured":"Waring, M. J. Complex formation between ethidium bromide and nucleic acids. J. Mol. Biol. 13, 269\u2013282 (1965).","journal-title":"J. Mol. Biol."},{"key":"1725_CR141","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/glia.20852","volume":"57","author":"EJ Vereyken","year":"2009","unstructured":"Vereyken, E. J., Fluitsma, D. M., Bolijn, M. J., Dijkstra, C. D. & Teunissen, C. E. An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures. Glia 57, 1326\u20131340 (2009).","journal-title":"Glia"},{"key":"1725_CR142","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/glia.23245","volume":"66","author":"JR Plemel","year":"2018","unstructured":"Plemel, J. R. et al. Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy. Glia 66, 327\u2013347 (2018).","journal-title":"Glia"},{"key":"1725_CR143","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00210-024-03314-1","volume":"398","author":"A Rayatpour","year":"2025","unstructured":"Rayatpour, A., Foolad, F. & Javan, M. Deferiprone promoted remyelination and functional recovery through enhancement of oligodendrogenesis in experimental demyelination animal model. Naunyn Schmiedebergs Arch. Pharmacol. 398, 715\u2013727 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"1725_CR144","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/299357a0","volume":"299","author":"K Mikoshiba","year":"1982","unstructured":"Mikoshiba, K. et al. Oligodendrocyte abnormalities in shiverer mouse mutant are determined in primary chimaeras. Nature 299, 357\u2013359 (1982).","journal-title":"Nature"},{"key":"1725_CR145","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1471-4159.1982.tb12560.x","volume":"39","author":"K Nagaike","year":"1982","unstructured":"Nagaike, K., Mikoshiba, K. & Tsukada, Y. Dysmyelination of shiverer mutant mice in vivo and in vitro. J. Neurochem. 39, 1235\u20131241 (1982).","journal-title":"J. Neurochem."},{"key":"1725_CR146","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.semcdb.2020.12.004","volume":"116","author":"SA Goldman","year":"2021","unstructured":"Goldman, S. A., Mariani, J. N. & Madsen, P. M. Glial progenitor cell-based repair of the dysmyelinated brain: progression to the clinic. Semin. Cell Dev. Biol. 116, 62\u201370 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1725_CR147","doi-asserted-by":"publisher","first-page":"103609","DOI":"10.1016\/j.xpro.2025.103609","volume":"6","author":"TM Tsarouchas","year":"2025","unstructured":"Tsarouchas, T. M., Zoupi, L., Williams, A. & Gibson, E. M. Protocol for assessing myelination by human iPSC-derived oligodendrocytes in Shiverer mouse ex vivo brain slice cultures. STAR Protoc. 6, 103609 (2025).","journal-title":"STAR Protoc."},{"key":"1725_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52444-w","volume":"15","author":"LJ Wagstaff","year":"2024","unstructured":"Wagstaff, L. J. et al. CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents. Nat. Commun. 15, 8570 (2024).","journal-title":"Nat. Commun."},{"key":"1725_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-004-0207-y","volume":"6","author":"K Inoue","year":"2005","unstructured":"Inoue, K. PLP1-related inherited dysmyelinating disorders: Pelizaeus\u2013Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6, 1\u201316 (2005).","journal-title":"Neurogenetics"},{"key":"1725_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42570-2","volume":"14","author":"J Groh","year":"2023","unstructured":"Groh, J. et al. Microglia-mediated demyelination protects against CD8+ T cell-driven axon degeneration in mice carrying PLP defects. Nat. Commun. 14, 6911 (2023).","journal-title":"Nat. Commun."},{"key":"1725_CR151","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-020-2494-3","volume":"585","author":"MS Elitt","year":"2020","unstructured":"Elitt, M. S. et al. Suppression of proteolipid protein rescues Pelizaeus\u2013Merzbacher disease. Nature 585, 397\u2013403 (2020).","journal-title":"Nature"},{"key":"1725_CR152","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.molmed.2024.03.005","volume":"30","author":"MS Elitt","year":"2024","unstructured":"Elitt, M. S. & Tesar, P. J. Pelizaeus\u2013Merzbacher disease: on the cusp of myelin medicine. Trends Mol. Med. 30, 459\u2013470 (2024).","journal-title":"Trends Mol. Med."},{"key":"1725_CR153","doi-asserted-by":"publisher","unstructured":"Laderach, F. et al. EBV induces CNS homing of B cells attracting inflammatory T cells. Nature https:\/\/doi.org\/10.1038\/s41586-025-09378-0 (2025).","DOI":"10.1038\/s41586-025-09378-0"},{"key":"1725_CR154","doi-asserted-by":"publisher","first-page":"eadp6325","DOI":"10.1126\/science.adp6325","volume":"387","author":"JP Lin","year":"2025","unstructured":"Lin, J. P. et al. 4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis-like lesions. Science 387, eadp6325 (2025).","journal-title":"Science"},{"key":"1725_CR155","doi-asserted-by":"publisher","first-page":"e2115973119","DOI":"10.1073\/pnas.2115973119","volume":"119","author":"N Sarrazin","year":"2022","unstructured":"Sarrazin, N. et al. Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction. Proc. Natl Acad. Sci. USA 119, e2115973119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1725_CR156","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13578-021-00729-8","volume":"11","author":"W Yang","year":"2021","unstructured":"Yang, W., Chen, X., Li, S. & Li, X. J. Genetically modified large animal models for investigating neurodegenerative diseases. Cell Biosci. 11, 218 (2021).","journal-title":"Cell Biosci."},{"key":"1725_CR157","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41420-025-02425-9","volume":"11","author":"G Poulen","year":"2025","unstructured":"Poulen, G. et al. Sex and age differences in glia and myelin in nonhuman primate and human spinal cords: implications for pathology. Cell Death Discov. 11, 129 (2025).","journal-title":"Cell Death Discov."},{"key":"1725_CR158","doi-asserted-by":"publisher","first-page":"105465","DOI":"10.1016\/j.nbd.2021.105465","volume":"158","author":"LS Sherman","year":"2021","unstructured":"Sherman, L. S. et al. A novel non-human primate model of Pelizaeus\u2013Merzbacher disease. Neurobiol. Dis. 158, 105465 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1725_CR159","doi-asserted-by":"publisher","first-page":"57","DOI":"10.21608\/jcvr.2020.90224","volume":"2","author":"ANE Abdallah","year":"2020","unstructured":"Abdallah, A. N. E., Shamaa, A. A. & El-Tookhy, O. S. Ethidium bromide induced demyelination of the central nervous system in a dog model of secondary progressive multiple sclerosis. J. Curr. Vet. Res. 2, 57\u201367 (2020).","journal-title":"J. Curr. Vet. Res."},{"key":"1725_CR160","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0300985817712794","volume":"55","author":"L Stimmer","year":"2018","unstructured":"Stimmer, L., Fovet, C. M. & Serguera, C. Experimental models of autoimmune demyelinating diseases in nonhuman primates. Vet. Pathol. 55, 27\u201341 (2018).","journal-title":"Vet. Pathol."},{"key":"1725_CR161","doi-asserted-by":"publisher","unstructured":"Levy, M. J. F., Garcia-Diaz, B., Sedel, F., Baron-Van Evercooren, A. & Mozafari, S. High dose pharmaceutical grade biotin (MD1003) accelerates differentiation of murine and grafted human oligodendrocyte progenitor cells in vivo. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232415733 (2022).","DOI":"10.3390\/ijms232415733"},{"key":"1725_CR162","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2017.09.002","volume":"86","author":"P Khare","year":"2018","unstructured":"Khare, P. et al. Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model. J. Autoimmun. 86, 104\u2013115 (2018).","journal-title":"J. Autoimmun."},{"key":"1725_CR163","doi-asserted-by":"publisher","first-page":"eadu5110","DOI":"10.1126\/sciadv.adu5110","volume":"11","author":"JR Allanach","year":"2025","unstructured":"Allanach, J. R. et al. Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis. Sci. Adv. 11, eadu5110 (2025).","journal-title":"Sci. Adv."},{"key":"1725_CR164","doi-asserted-by":"publisher","first-page":"116794","DOI":"10.1016\/j.celrep.2025.116794","volume":"45","author":"M Jin","year":"2026","unstructured":"Jin, M. et al. Chimeric brain models to study human glial\u2013neuronal and macroglial\u2013microglial interactions. Cell Rep. 45, 116794 (2026).","journal-title":"Cell Rep."},{"key":"1725_CR165","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin, J. et al. Humanized mouse models for immuno-oncology research. Nat. Rev. Clin. Oncol. 20, 192\u2013206 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1725_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.995477","volume":"15","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo, M., Mace, J. W. & Calabresi, P. A. Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis. Front. Mol. Neurosci. 15, 995477 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"1725_CR167","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.1523\/JNEUROSCI.3817-14.2015","volume":"35","author":"EG Baxi","year":"2015","unstructured":"Baxi, E. G. et al. Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice. J. Neurosci. 35, 8626\u20138639 (2015).","journal-title":"J. Neurosci."},{"key":"1725_CR168","doi-asserted-by":"publisher","first-page":"156544","DOI":"10.1016\/j.phymed.2025.156544","volume":"139","author":"M Sun","year":"2025","unstructured":"Sun, M. et al. Novel anti-inflammatory compounds that alleviate experimental autoimmune encephalomyelitis. Phytomedicine 139, 156544 (2025).","journal-title":"Phytomedicine"},{"key":"1725_CR169","doi-asserted-by":"publisher","unstructured":"Lira-Diaz, E. et al. EGF-coupled gold nanoparticles increase the expression of CNPase and the myelin-associated proteins MAG, MOG, and MBP in the septal nucleus demyelinated by cuprizone. Life https:\/\/doi.org\/10.3390\/life12030333 (2022).","DOI":"10.3390\/life12030333"},{"key":"1725_CR170","doi-asserted-by":"publisher","first-page":"105505","DOI":"10.1016\/j.neuint.2023.105505","volume":"164","author":"R Yamazaki","year":"2023","unstructured":"Yamazaki, R., Osanai, Y., Kouki, T., Huang, J. K. & Ohno, N. Pharmacological treatment promoting remyelination enhances motor function after internal capsule demyelination in mice. Neurochem. Int. 164, 105505 (2023).","journal-title":"Neurochem. Int."},{"key":"1725_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115435","volume":"209","author":"TK Motawi","year":"2023","unstructured":"Motawi, T. K., El-Maraghy, S. A., Kamel, A. S., Said, S. E. & Kortam, M. A. Modulation of p38 MAPK and Nrf2\/HO-1\/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of clemastine in EAE rat model. Biochem. Pharmacol. 209, 115435 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"1725_CR172","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407974121","volume":"121","author":"MM Poon","year":"2024","unstructured":"Poon, M. M. et al. Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. Proc. Natl Acad. Sci. USA 121, e2407974121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1725_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148648","volume":"1822","author":"EAB Gilbert","year":"2024","unstructured":"Gilbert, E. A. B. et al. Metformin treatment reduces inflammation, dysmyelination and disease severity in a mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis. Brain Res. 1822, 148648 (2024).","journal-title":"Brain Res."},{"key":"1725_CR174","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/brain\/awu358","volume":"138","author":"T Skripuletz","year":"2015","unstructured":"Skripuletz, T. et al. Pivotal role of choline metabolites in remyelination. Brain 138, 398\u2013413 (2015).","journal-title":"Brain"},{"key":"1725_CR175","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.4103\/1673-5374.373671","volume":"18","author":"V Gudi","year":"2023","unstructured":"Gudi, V., Grieb, P., Linker, R. A. & Skripuletz, T. CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial. Neural Regen. Res. 18, 2599\u20132605 (2023).","journal-title":"Neural Regen. Res."},{"key":"1725_CR176","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1117634","volume":"310","author":"M Platten","year":"2005","unstructured":"Platten, M. et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310, 850\u2013855 (2005).","journal-title":"Science"},{"key":"1725_CR177","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/aps.2012.181","volume":"34","author":"J Blazevski","year":"2013","unstructured":"Blazevski, J. et al. Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro. Acta Pharmacol. Sin. 34, 424\u2013431 (2013).","journal-title":"Acta Pharmacol. Sin."},{"key":"1725_CR178","doi-asserted-by":"publisher","first-page":"113460","DOI":"10.1016\/j.ab.2019.113460","volume":"587","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Safety assessment and antioxidant evaluation of betulin by LC\u2013MS combined with free radical assays. Anal. Biochem. 587, 113460 (2019).","journal-title":"Anal. Biochem."},{"key":"1725_CR179","doi-asserted-by":"publisher","first-page":"103520","DOI":"10.1016\/j.msard.2022.103520","volume":"58","author":"BM Escribano","year":"2022","unstructured":"Escribano, B. M. et al. Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Mult. Scler. Relat. Disord. 58, 103520 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1725_CR180","doi-asserted-by":"publisher","first-page":"963689724123304","DOI":"10.1177\/09636897241233045","volume":"33","author":"F Jamali","year":"2024","unstructured":"Jamali, F. et al. Human umbilical cord-derived mesenchymal stem cells in the treatment of multiple sclerosis patients: phase I\/II dose-finding clinical study. Cell Transplant. 33, 9636897241233045 (2024).","journal-title":"Cell Transplant."},{"key":"1725_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3597","volume":"4","author":"C Laterza","year":"2013","unstructured":"Laterza, C. et al. iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF. Nat. Commun. 4, 2597 (2013).","journal-title":"Nat. Commun."},{"key":"1725_CR182","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/glia.23950","volume":"69","author":"S Mozafari","year":"2021","unstructured":"Mozafari, S. et al. Beneficial contribution of induced pluripotent stem cell-progeny to Connexin 47 dynamics during demyelination\u2013remyelination. Glia 69, 1094\u20131109 (2021).","journal-title":"Glia"},{"key":"1725_CR183","doi-asserted-by":"publisher","first-page":"e3001166","DOI":"10.1371\/journal.pbio.3001166","volume":"19","author":"L Peruzzotti-Jametti","year":"2021","unstructured":"Peruzzotti-Jametti, L. et al. Neural stem cells traffic functional mitochondria via extracellular vesicles. PLoS Biol. 19, e3001166 (2021).","journal-title":"PLoS Biol."},{"key":"1725_CR184","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fimmu.2019.00238","volume":"10","author":"M Abbasi-Kangevari","year":"2019","unstructured":"Abbasi-Kangevari, M., Ghamari, S. H., Safaeinejad, F., Bahrami, S. & Niknejad, H. Potential therapeutic features of human amniotic mesenchymal stem cells in multiple sclerosis: immunomodulation, inflammation suppression, angiogenesis promotion, oxidative stress inhibition, neurogenesis induction, mmps regulation, and remyelination stimulation. Front. Immunol. 10, 238 (2019).","journal-title":"Front. Immunol."},{"key":"1725_CR185","doi-asserted-by":"publisher","first-page":"104222","DOI":"10.1016\/j.cellimm.2020.104222","volume":"358","author":"A De Paula Pohl","year":"2020","unstructured":"De Paula Pohl, A. et al. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression. Cell. Immunol. 358, 104222 (2020).","journal-title":"Cell. Immunol."},{"key":"1725_CR186","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/glia.24478","volume":"72","author":"V Mattera","year":"2024","unstructured":"Mattera, V., Occhiuzzi, F., Correale, J. & Pasquini, J. M. Remyelinating effect driven by transferrin-loaded extracellular vesicles. Glia 72, 338\u2013361 (2024).","journal-title":"Glia"},{"key":"1725_CR187","doi-asserted-by":"publisher","first-page":"e70170","DOI":"10.1111\/jnc.70170","volume":"169","author":"EH Moretti","year":"2025","unstructured":"Moretti, E. H., Lin, A. L. Y., Peruzzotti-Jametti, L., Pluchino, S. & Mozafari, S. Neural stem cell-derived extracellular vesicles for advanced neural repair. J. Neurochem. 169, e70170 (2025).","journal-title":"J. Neurochem."},{"key":"1725_CR188","doi-asserted-by":"publisher","unstructured":"Mozafari, S., Peruzzotti-Jametti, L. & Pluchino, S. Mitochondria transfer for myelin repair. J. Cereb. Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678X251325805 (2025).","DOI":"10.1177\/0271678X251325805"},{"key":"1725_CR189","doi-asserted-by":"publisher","first-page":"105487","DOI":"10.1016\/j.jbc.2023.105487","volume":"300","author":"D Qin","year":"2024","unstructured":"Qin, D., Wang, C., Li, D. & Guo, S. Exosomal miR-23a-3p derived from human umbilical cord mesenchymal stem cells promotes remyelination in central nervous system demyelinating diseases by targeting Tbr1\/Wnt pathway. J. Biol. Chem. 300, 105487 (2024).","journal-title":"J. Biol. Chem."},{"key":"1725_CR190","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13105-018-00660-6","volume":"75","author":"AEH Youssef","year":"2019","unstructured":"Youssef, A. E. H., Dief, A. E., El Azhary, N. M., Abdelmonsif, D. A. & El-Fetiany, O. S. LINGO-1 siRNA nanoparticles promote central remyelination in ethidium bromide-induced demyelination in rats. J. Physiol. Biochem. 75, 89\u201399 (2019).","journal-title":"J. Physiol. Biochem."},{"key":"1725_CR191","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2174\/1566523220666200306092556","volume":"19","author":"MA Islam","year":"2020","unstructured":"Islam, M. A., Kundu, S. & Hassan, R. Gene therapy approaches in an autoimmune demyelinating disease: multiple sclerosis. Curr. Gene. Ther. 19, 376\u2013385 (2020).","journal-title":"Curr. Gene. Ther."},{"key":"1725_CR192","doi-asserted-by":"publisher","first-page":"e106378","DOI":"10.1371\/journal.pone.0106378","volume":"9","author":"F Pourabdolhossein","year":"2014","unstructured":"Pourabdolhossein, F. et al. Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm. PLoS ONE 9, e106378 (2014).","journal-title":"PLoS ONE"},{"key":"1725_CR193","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409852122","volume":"122","author":"LM Rad","year":"2025","unstructured":"Rad, L. M. et al. Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis. Proc. Natl Acad. Sci. USA 122, e2409852122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1725_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58709-w","volume":"10","author":"AP Robinson","year":"2020","unstructured":"Robinson, A. P. et al. Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis. Sci. Rep. 10, 1936 (2020).","journal-title":"Sci. Rep."},{"key":"1725_CR195","doi-asserted-by":"publisher","first-page":"e2322577121","DOI":"10.1073\/pnas.2322577121","volume":"121","author":"C Natarajan","year":"2024","unstructured":"Natarajan, C. et al. Electrical stimulation of the vagus nerve ameliorates inflammation and disease activity in a rat EAE model of multiple sclerosis. Proc. Natl Acad. Sci. USA 121, e2322577121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1725_CR196","doi-asserted-by":"publisher","first-page":"103741","DOI":"10.1016\/j.autrev.2025.103741","volume":"24","author":"G Bjorklund","year":"2025","unstructured":"Bjorklund, G. et al. Cerebral iron accumulation in multiple sclerosis: pathophysiology and therapeutic implications. Autoimmun. Rev. 24, 103741 (2025).","journal-title":"Autoimmun. Rev."},{"key":"1725_CR197","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tibtech.2016.01.001","volume":"34","author":"S Aday","year":"2016","unstructured":"Aday, S., Cecchelli, R., Hallier-Vanuxeem, D., Dehouck, M. P. & Ferreira, L. Stem cell-based human blood\u2013brain barrier models for drug discovery and delivery. Trends Biotechnol. 34, 382\u2013393 (2016).","journal-title":"Trends Biotechnol."},{"key":"1725_CR198","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1097\/MS9.0000000000002231","volume":"86","author":"C Berjaoui","year":"2024","unstructured":"Berjaoui, C. et al. Neuroinflammation-on-a-chip for multiple sclerosis research: a narrative review. Ann. Med. Surg. 86, 4053\u20134059 (2024).","journal-title":"Ann. Med. Surg."},{"key":"1725_CR199","doi-asserted-by":"crossref","unstructured":"Papazian, I. et al. Spontaneous human CD8 T cell and EAE-inducible human CD4\/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive MS PBMC humanized mice. eLife 12, RP88826 (2024).","DOI":"10.7554\/eLife.88826"},{"key":"1725_CR200","doi-asserted-by":"publisher","unstructured":"Gingele, S. et al. Delayed demyelination and impaired remyelination in aged mice in the cuprizone model. Cells https:\/\/doi.org\/10.3390\/cells9040945 (2020).","DOI":"10.3390\/cells9040945"},{"key":"1725_CR201","doi-asserted-by":"publisher","first-page":"113039","DOI":"10.1016\/j.bbr.2020.113039","volume":"400","author":"G Cisbani","year":"2021","unstructured":"Cisbani, G. et al. The Intellicage system provides a reproducible and standardized method to assess behavioral changes in cuprizone-induced demyelination mouse model. Behav. Brain Res. 400, 113039 (2021).","journal-title":"Behav. Brain Res."},{"key":"1725_CR202","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","volume":"17","author":"JM Vega-Riquer","year":"2019","unstructured":"Vega-Riquer, J. M., Mendez-Victoriano, G., Morales-Luckie, R. A. & Gonzalez-Perez, O. Five decades of cuprizone, an updated model to replicate demyelinating diseases. Curr. Neuropharmacol. 17, 129\u2013141 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"1725_CR203","doi-asserted-by":"publisher","unstructured":"Nosrati, H. & Nosrati, M. Artificial intelligence in regenerative medicine: applications and implications. Biomimetics https:\/\/doi.org\/10.3390\/biomimetics8050442 (2023).","DOI":"10.3390\/biomimetics8050442"},{"key":"1725_CR204","doi-asserted-by":"publisher","unstructured":"Tasker, L., Getty, S. F., Briggs, J. R. & Benka, V. A. W. Exploring the gaps in practical ethical guidance for animal welfare considerations of field interventions and innovations targeting dogs and cats. Animals https:\/\/doi.org\/10.3390\/ani8020019 (2018).","DOI":"10.3390\/ani8020019"},{"key":"1725_CR205","first-page":"318","volume":"19,","author":"F Pappalardo","year":"2018","unstructured":"Pappalardo, F., Rajput, A. M. & Motta, S. Computational modeling of brain pathologies: the case of multiple sclerosis. Brief. Bioinform. 19, 318\u2013324 (2018).","journal-title":"Brief. Bioinform."},{"key":"1725_CR206","doi-asserted-by":"publisher","first-page":"1362629","DOI":"10.3389\/fimmu.2024.1362629","volume":"15","author":"AV De Keersmaecker","year":"2024","unstructured":"De Keersmaecker, A. V. et al. A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial. Front. Immunol. 15, 1362629 (2024).","journal-title":"Front. Immunol."},{"key":"1725_CR207","doi-asserted-by":"publisher","first-page":"115191","DOI":"10.1016\/j.bbr.2024.115191","volume":"476","author":"S Jallouli","year":"2025","unstructured":"Jallouli, S. et al. 12-Week melatonin supplementation improved dynamic postural stability and walking performance in persons living with multiple sclerosis: a randomized controlled trial. Behav. Brain Res. 476, 115191 (2025).","journal-title":"Behav. Brain Res."},{"key":"1725_CR208","doi-asserted-by":"publisher","first-page":"757795","DOI":"10.3389\/fneur.2021.757795","volume":"12","author":"MT Haindl","year":"2021","unstructured":"Haindl, M. T. & Hochmeister, S. Vitamin D in multiple sclerosis\u2014lessons from animal studies. Front. Neurol. 12, 757795 (2021).","journal-title":"Front. Neurol."},{"key":"1725_CR209","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.2025.1604","volume":"333","author":"E Thouvenot","year":"2025","unstructured":"Thouvenot, E. et al. High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis: the D-Lay MS randomized clinical trial. JAMA 333, 1413\u20131422 (2025).","journal-title":"JAMA"},{"key":"1725_CR210","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10571-009-9451-x","volume":"30","author":"M Goudarzvand","year":"2010","unstructured":"Goudarzvand, M., Javan, M., Mirnajafi-Zadeh, J., Mozafari, S. & Tiraihi, T. Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide. Cell Mol. Neurobiol. 30, 289\u2013299 (2010).","journal-title":"Cell Mol. Neurobiol."},{"key":"1725_CR211","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S1474-4422(20)30347-1","volume":"19","author":"BAC Cree","year":"2020","unstructured":"Cree, B. A. C. et al. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 19, 988\u2013997 (2020).","journal-title":"Lancet Neurol."},{"key":"1725_CR212","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","volume":"30","author":"MA Leone","year":"2023","unstructured":"Leone, M. A. et al. Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell 30, 1597\u20131609 (2023).","journal-title":"Cell Stem Cell"},{"key":"1725_CR213","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41591-022-02097-3","volume":"29","author":"A Genchi","year":"2023","unstructured":"Genchi, A. et al. Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. Nat. Med. 29, 75\u201385 (2023).","journal-title":"Nat. Med."},{"key":"1725_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08425-x","volume":"25","author":"N Stevens","year":"2024","unstructured":"Stevens, N. et al. A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis. Trials 25, 598 (2024).","journal-title":"Trials"}],"container-title":["Lab Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01725-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01725-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01725-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:02:22Z","timestamp":1780495342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01725-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":214,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1725"],"URL":"https:\/\/doi.org\/10.1038\/s41684-026-01725-6","relation":{},"ISSN":["0093-7355","1548-4475"],"issn-type":[{"value":"0093-7355","type":"print"},{"value":"1548-4475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.P. is founder, chief scientific officer and shareholder (>5%) of CITC Ltd. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}